Company registration number 12433020 (England and Wales)
HNV MEDICAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
PAGES FOR FILING WITH REGISTRAR
HNV MEDICAL LIMITED
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 4
HNV MEDICAL LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 JANUARY 2026
31 January 2026
- 1 -
2026
2025
Notes
£
£
£
£
Non-current assets
Property, plant and equipment
3
31,847
39,808
Current assets
Trade and other receivables
16,432
16,432
Cash and cash equivalents
17,584
5,434
34,016
21,866
Current liabilities
(8,363)
(4,348)
Net current assets
25,653
17,518
Net assets
57,500
57,326
Equity
Called up share capital
200
200
Retained earnings
57,300
57,126
Total equity
57,500
57,326

For the financial year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with section 444 of the Companies Act 2006, all of the members of the company have consented to the preparation of abridged financial statements pursuant to paragraph 1A of Schedule 1 to the Small Companies and Groups (Accounts and Directors’ Report) Regulations (SI 2008/409)(b).

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 22 May 2026 and are signed on its behalf by:
Dr Haren Nitin Varia
Director
Company registration number 12433020 (England and Wales)
HNV MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
- 2 -
1
Accounting policies
Company information

HNV Medical Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 7 Navigation Business Village, Navigation Way, Ashton-On-Ribble, Preston, Lancashire, United Kingdom, PR2 2YP.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

1.2
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus, the directors continue to adopt the going concern basis of accounting in preparing the financial statements.true

1.3
Revenue

Turnover comprises the invoice value of private medical services supplied by the company, exclusive of trade discounts.

1.4
Property, plant and equipment

Property, plant and equipment are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
20% Reducing balance
Motor vehicles
15% Reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

HNV MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 3 -
Basic financial assets

Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including trade and other payables, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

HNV MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 4 -
2
Employees

During the current period, there were no employees, the directors did not receive any remuneration or pension benefits, and both directors served.

2026
2025
Number
Number
Total
2
2
3
Property, plant and equipment
Fixtures and fittings
Motor vehicles
Total
£
£
£
Cost
At 1 February 2025 and 31 January 2026
6,616
59,061
65,677
Depreciation and impairment
At 1 February 2025
3,079
22,790
25,869
Depreciation charged in the year
707
7,254
7,961
At 31 January 2026
3,786
30,044
33,830
Carrying amount
At 31 January 2026
2,830
29,017
31,847
At 31 January 2025
3,537
36,271
39,808
2026-01-31 2025-02-01 false false false 22 May 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Dr Haren Nitin Varia Dr Meenakshi Varia 12433020 2025-02-01 2026-01-31 12433020 2026-01-31 12433020 2025-01-31 12433020 core:FurnitureFittings 2026-01-31 12433020 core:MotorVehicles 2026-01-31 12433020 core:FurnitureFittings 2025-01-31 12433020 core:MotorVehicles 2025-01-31 12433020 core:CurrentFinancialInstruments core:WithinOneYear 2026-01-31 12433020 core:CurrentFinancialInstruments core:WithinOneYear 2025-01-31 12433020 core:ShareCapital 2026-01-31 12433020 core:ShareCapital 2025-01-31 12433020 core:RetainedEarningsAccumulatedLosses 2026-01-31 12433020 core:RetainedEarningsAccumulatedLosses 2025-01-31 12433020 bus:Director1 2025-02-01 2026-01-31 12433020 core:FurnitureFittings 2025-02-01 2026-01-31 12433020 core:MotorVehicles 2025-02-01 2026-01-31 12433020 2024-02-01 2025-01-31 12433020 core:FurnitureFittings 2025-01-31 12433020 core:MotorVehicles 2025-01-31 12433020 2025-01-31 12433020 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 12433020 bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 12433020 bus:FRS102 2025-02-01 2026-01-31 12433020 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 12433020 bus:Director2 2025-02-01 2026-01-31 12433020 bus:FullAccounts 2025-02-01 2026-01-31 xbrli:pure xbrli:shares iso4217:GBP